Conatus (CNAT), Galmed (GLMD), Intercept (ICPT) Could Be Given Similar Considerations for their Assets - FBR

September 20, 2016 10:54 AM EDT Send to a Friend
FBR Capital analyst Vernon Bernardino weighed in on the NASH space after Allergan (NASDAQ: AGN) agreed to acquire Tobira Therapeutics ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login